Deadline Extended: DF/HCC Kidney Cancer SPORE Developmental Research Project Awards (Now Due 08/24/2020)

August 04, 2020

The Kidney Cancer SPORE of the Dana Farber/Harvard Cancer Center, under the leadership of Drs. David McDermott and William Kaelin, seeks applications for funding of research on kidney cancer. Funding will be provided through the Kidney Cancer Specialized Program of Research Excellence (SPORE) mechanism, a National Cancer Institute sponsored program (P50CA101942-16). Applications must include one investigator on the faculty at Harvard Medical School at the level of Instructor or higher. While the proposed research can be basic or clinical, bench to bedside and bedside to bench strategies need to be addressed, since the purpose of this program is to promote translational research in kidney cancer. Applications will be judged on their scientific merit, relevance to kidney cancer, potential for future translation to clinical application, qualifications of the research team and the potential fit within the overall activities of the DF/HCC Kidney Cancer Program/Kidney Cancer SPORE. Funding will be up to $50,000 in direct costs (F&A at the institutions federally negotiated rate) for one year. Although the opportunity exists for extending funding beyond one year, proposals should, in general, focus on a year’s worth of research. Applications should be sent electronically in to Tara Johnston, Program Administrator at tjohnst1@bidmc.harvard.edu no later than noon on 08/24/2020. A prior track record in kidney cancer research is preferred but not necessary. Minority and women applicants are strongly encouraged to apply.

Applications must contain the following components on PHS 398 Forms:

  1.  Institutional Signature  provided on a Letter of Intent to collaborate for non BIDMC applicants
  2. Cover letter : Include Title of proposal, PI, Institution and research administration contact.
  3. Abstract : Include of proposed research
  4. Research Proposal : Include 1) Specific Aims 2) Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages. Reference and Budget pages are not included in this page limit. Appendix material not required.
  5. Translational Goals  of the project, potential application to kidney cancer and anticipated timeline (1 page)
  6. NIH Biosketch and Other Support : Current NIH Biosketch and any collaborators including funding sources
  7. Budget Request and Justification:  Must be submitted on the NIH 398 budget form and must not exceed Direct Costs of $50,000. Funds cannot be used for the purchase of any large equipment.
  8. NIH Checklist
  9. IRB/IACUC  approval documents (if applicable)
  10. Human Subject Training  Certificate (if applicable)
  11. Submit  all documents as one pdf file. Pages should be numbered.

Anticipated Award Dates: 09/01/2020 – 08/31/21
We anticipate being able to fund 1-2 projects for that project period.